It was described that BrP-LPA, which acts as both pan-LPA GPCR antagonist and ATX inhibitor, was effective in reducing liver metastasis of HCT116 human colon cancer cells, but a full account of this study is yet to be reported [68]. The gene discussed is ENPP2; the disease is colonic neoplasm.